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ABSTRACT 
Scope: Bifidobacteria play a role in intestinal homeostasis but molecular mechanisms remain 
under-investigated. The aim of this study was to assess if probiotic Bifidobacterium strains 
alter expression of intestinal microRNA and downstream target gene response. 
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Methods and results: The expression of miR-148a and its validated target EPAS1 
(endothelial PAS domain protein 1) was analyzed in Caco-2 cells and mice cecum in 
response to Bifidobacterium bifidum MIMBb75, B. bifidum NCC390 or B. longum NCC2705.  
In vitro, exposure to B. bifidum MIMBb75, but not to B. bifidum NCC390 or B. longum 
NCC2705, increased the expression of miR-148a after 1 and 4 hours (P <0.01), but not after 
24h. In vivo, B. bifidum MIMBb75 administration to C57BL/6J mice increased miR-148a 
expression in the cecum after 2 but not 14 days (P< 0.05). The increase of miR-148a was 
accompanied by a decrease of EPAS1 expression in Caco-2 cells and cecum (P<0.05). 
Silencing of miR-148a reversed B. bifidum MIMBb75-dependent downregulation of EPAS1. 
Conclusion: This study shows an early response of intestinal cells to B. bifidum MIMBb75 
through miR-148a modulation. This brings a new concept of strain- and time-dependent 
bifidobacteria-host crosstalk via microRNA. Probiotic B. bifidum MIMBb75 may help 
attenuating EPAS1 overexpression associated with intestinal inflammation. 
 
1 Introduction  
Bifidobacteria are autochthonous inhabitants of human and animal intestinal tracts, 
representing 80 and 25 % of the infant and adult microbiota, respectively (Reviewed in [1]). 
This genus comprises widely used probiotics whose benefits are either considered common 
probiotic core benefits, such as their ability to improve gut microbiota composition [2, 3] and 
inhibit pathogen adhesion [4], or are strain specific, particularly, their capability to modulate 
the host-immune system [5]. This is in line with the ability of bifidobacteria to elicit host 
responses in a species- and strain- dependent manner [5-7]. Bifidobacterium bifidum 
MIMBb75 is a probiotic strain isolated from healthy human feces [8], that resides in cecal-
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colonic regions and modulates the composition of the gut microbiota in mice [9]; in a double-
blind placebo-controlled study, it was shown to significantly reduce irritable bowel syndrome 
(IBS) symptoms and improve general quality of life [10]. B. bifidum MIMBb75 has stronger 
ability to adhere to intestinal cells in vitro compared to other probiotics such as B. longum 
NCC2705 and Lactobacillus rhamnosus GG [11]. B. bifidum MIMBb75 possesses several 
surface proteins that could enable interaction with host cells. These include the 
bifidobacterial outer protein (BopA), likely involved in the adhesion process [8], and the 
murine lytic enzyme TgaA, expressed on the outer surface of B. bifidum MIMBb75 cells and 
found to activate dendritic cells and trigger IL-2 production in vitro [12, 13]. However, the 
response of the host to B. bifidum MIMBb75 remains largely uncharacterized, particularly at 
the molecular level. Gene expression regulation is a main mechanism underpinning the 
continuous interaction between intestinal tissues and microbiota. The coexistence of 
prokaryotic and eukaryotic cells in the intestine results in a microbiota-dependent gene 
expression program in host cells [14, 15]. Not surprisingly, this is affected by probiotic 
administration, including bifidobacteria [16]. We and others have shown that the intestinal 
microbiota-dependent gene regulation may occur at the post-transcriptional level, via 
microRNA, in colon and cecum [17, 18]. MicroRNAs (miRNAs) are 20-22 nucleotides long, 
non-coding RNAs regulating more than 60% of the human transcriptome [19]. MiRNAs have 
emerged as fine-tuners of host gene expression contributing to intestinal homeostasis 
(Reviewed in [20]. Like mRNA, miRNAs are expressed in a time-dependent manner [21, 22], 
acting as a response timer to a variety of stimuli. The time-specific response can happen early 
(within a few hours) such as in gastric epithelial cells exposed to Helicobacter pylori (6 
hours) [23] or can be delayed (within days), such as in T lymphocytes where miR146a levels 
were increased after 8 days to stimulation with PMA (phorbol myristate acetate) and 
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ionomycin, reaching their highest level of expression after 20 days [24]. MiRNA responses to 
commensal or probiotic bacteria have not been largely investigated. We found that the 
presence of the microbiota impacts the intestinal miRNA signature including expression of 
miR-148a [18]. MiR-148a is a member of the miR-148/152 family (reviewed in [25]) known 
to play an important role in the regulation of the immune response [26]. Here, we studied the 
impact of probiotic B. bifidum MIMBb75 on intestinal expression of miR-148a and the 
downstream target gene response in vitro and in vivo.  
2 Materials and methods 
Bifidobacteria 
B. bifidum MIMBb75, B. bifidum NCC390 and B. longum NCC2705 were grown overnight at 
37°C in MRS broth (Difco, Detroit, MI, USA) supplemented with 0.05% L-cysteine 
hydrochloride (cMRS) in an anaerobic chamber (Coy Laboratory Products; Grass Lake, MI, 
USA) containing an atmosphere of 90% N2, 5% H2 and 5% CO2. Prior to use, cells were 
harvested at 3000 × g for 10 min, washed twice with phosphate-buffered saline (PBS) and 
quantified microscopically using Neubauer Bright-Line Hemacytometer (Hausser Scientific, 
Horsham, PA) and by plating on cMRS Agar.  
Caco-2 cell culture, co-incubation and transfection experiments 
Caco-2 cells were obtained from the American Type Culture Collection (ATCC, Rockville, 
MD, USA) and were routinely cultured at 37°C in Dulbecco’s modified Eagle’s medium 
(DMEM), as previously described [8]. Prior to co-incubation with Bifidobacterium strains, 
the cells were seeded on 6-well culture plates and grown for two weeks post-confluency [8]. 
The fully differentiated Caco-2 monolayers were washed with PBS buffer and incubated in 
parallel with each of the test strain re-suspended in DMEM vehicle without antibiotics, 
supplemented with 100 mM HEPES (GIBCO, Life Technologies, Carlsbad, CA, USA) at 
www.mnf-journal.com Page 5 Molecular Nutrition & Food Research 
 
 
This article is protected by copyright. All rights reserved. 
5 
bacteria:cell ratio of 10:1 for 1, 4 and 24h. Vehicle alone was used as a control. After 
incubation, cells were washed with PBS, scraped off the bottom of the wells, snap-frozen in 
liquid nitrogen and stored at -80°C until RNA extraction. Cell viability was determined by 
Trypan Blue exclusion test (GIBCO, Life Technologies, Carlsbad, USA), whereas bacterial 
viability was evaluated by plating on cMRS Agar both at the time of addition and after 
incubation with the cells. Experiments were conducted in triplicates.  
For transfection with miRNA inhibitors, Caco-2 cells were seeded on 6-well culture plates at 
a density of 10
6
 cell/well to reach 60 to 80% of confluency at the time of transfection. Cells 
were transfected with 10 nM of mirVana miR-148a inhibitor (Assay ID: MH10263), mirVana 
let-7c miRNA inhibitor (positive control, Assay ID: 4464080) (Invitrogen, Life 
Technologies, Carlsbad, USA), or corresponding vehicle alone (Mock) using lipofectamine 
RNAiMAX transfection agent and Opti-MEMI reduced serum medium (Invitrogen, life 
Technologies, Carlsbad, CA, USA), according to the manufacturer's instructions. The 
transfection efficiency was evaluated with Block-iT Fluorescent Oligo (Invitrogen, Life 
Technologies, Carlsbad, USA) according to the manufacturer’s protocol. At 72 h post-
transfection, miR-148a inhibitor- or mock- transfected cells were incubated with either B. 
bifidum MIMBb75, prepared as described above, at bacteria:cell ratio of 10:1 or vehicle 
alone, for 1, 4 and 24h. 
In vivo probiotic studies 
Two studies were conducted. The first, which has been partially described in [9], used twenty 
eight 5–6 weeks old C57BL/6J male mice purchased from Jackson’s Laboratory 
(Sacramento, CA, USA) and housed at the Division of Comparative Medicine, University of 
Toronto. After one week acclimatization, mice were randomized into two groups 
(n=14/group) to receive 0.2 ml of PBS containing 10
8 
colony forming units (CFU) of B. 
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bifidum MIMBb75 cells or PBS only daily for 2 or 14 days, via intragastric gavage. The 
second study used twelve C57BL/6J male mice at the same age and from the same origin as 
above. Mice received either B. bifidum MIMBb75 or PBS for 2 days (n=4-8/group). Viability 
and quantity of B. bifidum MIMBb75 used for gavage were confirmed by plating on cMRS 
Agar. Cecal tissues and contents were collected immediately after dissection on ice and 
stored at -80°C. All animal experiments were approved by the animal ethics committee at the 
University of Toronto (Protocol number: 20010228). Microbiota composition analysis was by 
qPCR using TaqMan assays (Supporting Information Table S1), as we previously described 
[9]. 
RNA extraction and real-time quantitative PCR 
Total RNA was isolated from Caco-2 cells and mouse cecum tissues using the mirVana
TM
 
miRNA isolation kit (Ambion, Life Technologies, Carlsbad, USA), as per the manufacturer’s 
instructions. miRNA and mRNA expression analysis was performed as we described 
previously [18] (miR-148a, Assay ID: 000470; EPAS1, Assay IDs: Hs01026149_m1 and 
Mm01236112_m1 for Caco-2 cells and mouse cecum, respectively). MiRNA gene expression 
data were normalized to the endogenous controls RNU6B (Assay ID: 001093) and sno-135 
(Assay ID: 001230) for Caco-2 cells and mouse cecum, respectively. Gene expression was 
normalized to ACTB (Assay IDs: Hs01060665_g1 and Mm02619580_g1 for Caco-2 cells and 
mouse cecum, respectively). Fold changes were calculated using the 2
-ΔΔ
Ct method [27].  
Identification of microRNA targets 
Putative and experimentally validated targets of miR-148a were identified in silico using the 
miRWalk database which integrates seven different algorithms [28]. 
Statistical analysis 
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Statistical significance of miRNA and mRNA expression in Caco-2 cells was determined by 
one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison test. 
Significance of differential miRNA and gene expression mouse cecum was assessed with the 
Mann-Whitney test. GraphPad Prism software V5.0 (La Jolla, CA, USA) was used for all 
statistical analyses and values of p <0.05 were considered significant. Data are presented as 
mean ± SD.  
 
3 Results 
Bifidobacteria modify miR-148a expression in a strain- and time- dependent manner in vitro  
To investigate the miRNA response to bifidobacteria in intestinal cells, Caco-2 cells were 
incubated for 1, 4 or 24 hours with B. bifidum MIMBb75 or B. bifidum NCC390 or B. longum 
NCC2705. Caco-2 cells viability was ≥ 93% and viable counts of the three strains were in the 
range of 2 to 9x10
7
 CFU/well at all time points (data not shown). B. bifidum MIMBb75 
elicited an increase in miR-148a expression after 1 and 4 hours (3.5 ± 1.3 and 2.7 ± 0.7 fold 
changes, respectively, compared to the control, P <0.01) but not after 24 hours. This increase 
was more pronounced at the earliest time point. MiR-148a did not change in response to B. 
bifidum NCC390 and to B. longum NCC2705 (Figure 1). 
B. bifidum MIMBb75 modifies intestinal miR-148a expression in vivo  
To determine whether B. bifidum MIMBb75 modulates host intestinal miRNA expression in 
vivo, we first used tissue samples from a study we had previously conducted, where mice 
were daily gavaged with 10
8
 CFU of B. bifidum MIMBb75 or PBS (as a control) for 2 or 14 
days [9]. In the cecum of mice receiving probiotic, B. bifidum counts corresponded to 5.4 ± 
0.3 log CFU/g of contents at day 2, while C. coccoides levels were significantly decreased 
compared to the PBS gavaged mice (8.2 ± 0.1 versus 7.2 ± 0.7 log CFU/g of contents, 
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P=0.01) (Supporting Information Figure S1); other taxa known to be represented in the gut 
microbiota, including C. leptum group, were not affected (data not shown). Bacterial counts 
at day 14 were previously published and showed the same pattern with significantly increased 
B. bifidum counts and decreased C. coccoides levels in the cecum of mice receiving probiotic 
[9]. B. bifidum counts increased after 14 days of continuous administration; there was no 
within group difference between C. coccoides counts at the two time points. The caecal 
expression of miR-148a increased after two days of probiotic treatment (1.4 ± 0.1 fold 
change, P=0.002) but not after 14 days (0.9 ± 0.3 fold change) (Figure 2 A). Data at day 2 
were confirmed in a second independent study showing B. bifidum counts of 6.0 ± 0.4 log 
CFU/g of cecum content and a significant decrease of C. coccoides counts in mice receiving 
probiotics compared to the control (6.0 ± 0.4 versus 4.4 ± 0.2 log CFU/g of contents, 
P=0.001) (Supporting Information Figure S1). MiR-148a expression was significantly 
increased (1.7 ± 0.2 fold change, P=0.005) (Figure 2 B). These data follow a similar pattern 
as in Caco-2 cells where the expression of host miR-148a is altered in response to B. bifidum 
MIMBb75 administration with an early response that differs from that at later time-points. 
Identification of miR-148a targets 
To address the role of miR-148a in host intestinal response to probiotic B. bifidum 
MIMBb75, its gene targets were identified using seven different algorithms. Over 1760 
predicted putative targets for miR-148a were found by at least five of these (Supporting 
Information Table S2); 78 experimentally validated targets were identified including EPAS1 
(Supporting Information Table S3). This gene encoding for endothelial PAS domain protein 1 
(also known as Hypoxia-inducible factor-2 alpha, HIF-2α), was identified by five of the 
seven interrogated algorithms. Previous studies using mesenchymal stem cells had 
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experimentally verified that miR-148a controls the expression of EPAS1 [29]. Thus, this gene 
was selected for additional investigation in vitro and in vivo.  
MiR-148a impacts expression of EPAS1 in intestinal epithelial cells exposed to B. bifidum 
MIMBb75a 
To determine if miR-148a regulates the expression of its target gene EPAS1 in Caco-2 cells 
in response to B. bifidum MIMBb75, miR-148a was inhibited for 3 days. Then, miR-148a-
inhibited or mock transfected Caco-2 cells were incubated with B. bifidum MIMBb75 for 1, 4 
and 24 hours and miR-148a and EPAS1 expression levels were measured by RT-qPCR. To 
ensure the miRNA inhibition was successful, miR-148a expression levels were also 
determined in intestinal cells transfected with miR-148a-inhibitor and incubated in the 
presence of vehicle alone (DMEM without antibiotics, supplemented with 100 mM HEPES) 
for 1, 4 and 24 hours. Silencing of miR-148a was efficient since cells transfected with miR-
148a inhibitor had a 50 % decrease in miR-148a expression compared to control (miR-148a 
inhibitor) (Figure 3). In cells transfected with miR-148a inhibitor and co-incubated with B. 
bifidum MIMBb75 (miR-148a inh+BB75), silencing was overcome at 4 and 24 hours, 
showing the ability of B. bifidum MIMBb75 to increase the expression of miR-148a. In line 
with experiments in Figure 1, miR-148a increased after 1 and 4 hours of co-incubation of 
mock-transfected cells with B. bifidum MIMBb75 (BB75 only). 
As shown in Figure 4A, inhibition of miR-148a significantly affected EPAS1 expression 
compared to the control (miR-148a inhibitor), with more than 200% increase in gene 
expression in the miR-148a silenced group in response to the probiotic strain at 4 hours (miR-
148a inh+BB75) (P< 0.001). This gene was also found to be significantly downregulated in 
the cecum of mice gavaged with B. bifidum MIMBb75 for 2 days (0.8 ± 0.1 fold change, 
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P=0.004) (Figure 4B). This indicates that down-regulation of EPAS1 gene expression by B. 
bifidum MIMBb75 is mediated by miR-148a.  
4 Discussion 
In this study, we showed that the expression of miR-148a is altered in intestinal cells in 
response to bifidobacteria in a strain and time-dependent manner. In particular, exposure to B. 
bifidum MIMBb75 induces an early upregulation of miR-148a both in vitro and in vivo, 
which disappears at later time points. Very few studies have investigated the effect of 
selected probiotic on miRNA expression. L. rhamnosus GG was found to increase the 
expression of miR-155 and decrease miR-146a in human dendritic cells [30]. Escherichia 
coli Nissle 1907 increased tight junction protein expression in T84 cells via miR-595, miR-
483 and miR-203 downregulation [31]. Heat-treated L. paracasei NCC 2461 downregulated 
miR-27a in peripheral blood mononuclear cells [32]. Enterococcus faecium NCIMB 10415 
upregulated miR-423-5p and downregulated its target gene IGLC (immunoglobulin lambda 
light C region) in the intestine of piglets [33]. These studies show that different probiotics 
elicit different miRNA responses. Though, none of them examined the effects of different 
probiotics on the same miRNA species. We found that, opposite to B. bifidum MIMBb75, B. 
longum NCC2705 and B. bifidum NCC390 did not affect miR-148a expression. The 
molecular mechanisms behind this strain- specific response are not clear. Recently, B. 
bifidum MIMBb75 whole genome sequencing revealed the presence of a gene named tgaA 
coding for a murein lytic enzyme TgaA [12]. This peptidoglycan-degrading enzyme was 
shown to exert an immunomodulatory effect by inducing DCs activation and IL-2 production 
through its C-terminal CHAP (cysteine histidine-dependent amidohydrolase/peptidase) 
domain in a strain-dependent manner, with B. bifidum MIMBb75 showing the strongest effect 
[13]. Therefore, it is tempting to speculate that miRNA-mediated B. bifidum MIMBb75-host 
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interaction depends on the CHAP domain of TgaA. Two extracellular proteins encoded by B. 
bifidum, the sortase-dependent pili and the type IV tight adherence locus have been shown to 
mediate its interaction with the host [34-36]. However, opposite to TgaA, these proteins are 
encoded by genes identified in B. bifidum core genome [37], and are thus unlikely to explain 
strain specific responses. Microbial metabolites such as short chain fatty acids may regulate 
host gene expression epigenetically [38] offering a possible alternate mechanism for host 
miRNA modulation. The microbiota is a modifier of the intestinal miRNA response to 
pathogen exposure, in that the expression of miR-148a was reduced in the intestine of 
conventional, but not germ-free mice, infected with Listeria monocytogenes [39]. B. bifidum 
MIMBb75 modifies the microbiota, resulting in increased bifidobacteria and decreased C. 
coccoides counts (this study and [9]). Though, this is already evident at day 2, with no 
differences between day 2 and 14. Thus, there could be a “direct” effect of B. bifidum 
MIMBb75 which is not mediated by the microbiota. Though, given its complexity and 
because the effect of B. bifidum MIMBb75 administration on its composition and activity 
have not been completely elucidated yet, future studies including microbiota profiling are 
necessary.  
MiRNAs respond to bacterial stimuli in a time-dependent manner. For example, pri-miR-147 
increased in murine peritoneal macrophages after 2, but not 6 hours of exposure to 
lipopolysaccharide [40] and the expression of miR-146a in gastric epithelial cells increased 
between 6-9 hours after H. pylori infection, but decreased after 24 h [23]. However, the 
deferred response to bacterial exposure has not been investigated in the literature. Early 
responses have been deemed essential in innate immune responses where a short reaction 
time is critical for resistance for example to a pathogenic microorganism. On the other hand, 
delayed responses may play a role in adaptive immunity [24]. Thus, our data suggest that the 
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intestine may adapt to B. bifidum MIMBb75 following continued exposure. The time of 
exposure to a probiotic is a critical factor in clinical practice because it dictates the 
administration protocol. A time-dependent response following probiotic exposure was found 
in vitro and in vivo (mouse cecum) for B. bifidum PRL2010 impacting the immune response 
via alteration of the gene expression signature of HT-29 cells with more consistent changes 
after 4, rather than 1 or 2, hours of co-incubation[41], and in vivo for Lactobacillus reuteri 
100-23 impacting inflammatory pathways after 6 but not 21 days of colonization [42]. Taken 
together with our findings, these data suggest that there may be an immediate intestinal 
response to probiotic exposure which may vary from that resulting from repetitive re-
inoculation. This concept aligns with a study showing that, opposite to continuous 
supplementation, pulse administration of probiotics maintains high expression levels of 
mucin 3 in the jejunum and ileum of rats [43]. 
Based on in silico analysis, several genes were identified as potential targets of miR-148a, 
including experimentally validated EPAS1. This is a hypoxia-inducible transcription factor of 
the basic helix-loop-helix/PAS domain family, also known as Hypoxia Inducible Factor-2α 
(HIF-2α) [44]. High levels of EPAS1 have been associated with digestive system cancers 
(Reviewed in [45]), IBD [46] and colitis [47]. In a mouse model, EPAS1 was found to 
activate mediators of inflammation such as TNF-α and to promote colonic inflammation and 
spontaneous colitis after Citrobacter rodentium infection or dextran sulfate sodium (DSS) 
administration [47]. Moreover, it has a role in activating iron transporters [48] and intestinal 
knockout of EPAS1 significantly decreased tissue iron accumulation, due to a decrease in 
iron absorptive genes, in a mouse model of sickle cell disease (SDC) [49]. Therefore, 
intestinal EPAS1 has been suggested as a therapeutic target for IBD [47], SCD [49] and 
different types of cancers [50]. Here, we found that B. bifidum MIMBb75 increased miR-
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148a resulting in down-regulation of EPAS1 in colonic cells. This suggests that B. bifidum 
MIMBb75 could be considered for maintenance of, or to restore, intestinal homeostasis.  
In conclusion, our study brings a new concept of strain specific bifidobacteria-host crosstalk 
mediated by microRNA. Our findings show that B. bifidum MIMBb75 stimulates gene 
expression changes in the host at both the transcriptional and miRNA levels in a time-
dependent manner. Although speculative at this stage, the use of B. bifidum MIMBb75 may 
be considered to inhibit EPAS1 function in intestinal cells and as a consequence help in 
preventing or mitigating colitis and other diseases. Molecular antagonists of EPAS1 have 
been identified [51], providing therapeutic opportunities to its inactivation in disease. Our 
study is the first to show an alternative way to achieve EPAS1 inhibition in intestinal cells 
that is mediated by miRNA in response to a probiotic. This warrants further research to better 
elucidate the mechanisms involved. In addition, timing of probiotic administration may play 
an important role in clinical practice. 
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Figure legends  
Figure 1. Strain- and time-specific expression of miR-148a in Caco-2 intestinal cells in 
response to bifidobacteria.  
Relative expression in intestinal Caco-2 cells incubated in presence of Bifidobacterium 
strains for 1, 4 and 24 hours. Data are presented as relative fold change in Caco-2 cells co-
incubated with one of the three strains (B. bifidum MIMBb75, B. bifidum NCC390 or B 
longum NCC2705) compared to sterile vehicle with delta Cts normalized to RNU6B. 
Significance is based on ANOVA plus Tukey’s multiple comparisons test. *P<.05, **P<.01 
and ***P<.001. The average of three biological replicates with corresponding standard 
deviations are presented. 
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Figure 2. The expression of miR-148a increases early in mouse cecum following 
administration of B. bifidum MIMBb75 
Relative expression in mice cecum following intragastric gavage of either B. bifidum 
MIMBb75 or sterile PBS for two and fourteen days in study 1 (A) and or for two days in 
study 2 (B). Data are presented as relative fold change in B. bifidum MIMBb75 versus control 
group, with delta Cts normalized to snoRNA-135. Significance is based on non-parametric 
Mann-Whitney test. *P<.05, **P<.01 and ***P<.001. The average of 4 to 7 mice per group 
corresponding standard deviations are presented. 
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Figure 3. B. bifidum MIMBb75 modifies the expression of silenced miR-148a in Caco-2 
cells 
Relative expression of miR-148a in transfected Caco-2 cells co-incubated B. bifidum 
MIMBb75 or sterile vehicle for 1, 4 and 24 hours. Data are presented as relative fold change 
in a) miR-148a inhibitor transfected Caco-2 cells incubated with vehicle only (miR-148a 
inhibitor), b) miR-148a inhibitor transfected Caco-2 cells incubated with B. bifidum 
MIMBb75 (miR-148a inh+MIMBb75) and c) mock transfected Caco-2 cells incubated with 
B. bifidum MIMBb75 (MIMBb75 only), with delta Cts normalized to RNU6B. Significance 
is based on ANOVA plus Tukey’s multiple comparisons test. *P<.05, **P<.01 and 
***P<.001. The average of three biological replicates with corresponding standard deviations 
are presented. 
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Figure 4. B. bifidum MIMBb75 downregulates EPAS1 in intestinal cells via miR-148a in 
a time-dependent manner.  
Relative expression of EPAS1 in transfected Caco-2 cells co-incubated with B. bifidum 
MIMBb75 or sterile vehicle for 1, 4 and 24 hours (A). Data are presented as relative fold 
change in a) miR-148a inhibitor transfected Caco-2 cells incubated with vehicle only (miR-
148a inhibitor), b) miR-148a inhibitor transfected Caco-2 cells incubated with B. bifidum 
MIMBb75 (miR-148a inh+MIMBb75) and c) mock transfected Caco-2 cells incubated with 
B. bifidum MIMBb75 (MIMBb75 only), with delta Cts normalized to RNU6B. Significance 
is based on ANOVA plus Tukey’s multiple comparisons test. *P<.05, **P<.01 and 
***P<.001. The average of three biological replicates with corresponding standard deviations 
are presented. Relative expression in mice cecum receiving either B. bifidum MIMBb75 or 
sterile PBS by intragastric gavage for two days (B). Data are presented as relative fold change 
in B. bifidum MIMBb75 versus control group, with delta Cts normalized to Actb. Significance 
is based on non-parametric Mann-Whitney test. *P<.05. The average of 4 to 6 mice per group 
corresponding standard deviations are presented. 
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Graphical abstract 
 
We studied if probiotic bifidobacteria alter intestinal microRNA and downstream target gene 
response. We found that intestinal cells respond to Bifidobacterium bifidum exposure via 
increased expression of miR-148a in a time-dependent manner. At 1 hour, increase of miR-
148a results in decreased expression of its target gene endothelial PAS domain protein 1. 
EPAS1 is involved in intestinal cancers and inflammation; thus, B. bifidum could provide a 
strategy to support homeostasis via microRNA. 
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